Thr 446 phosphorylation of PKR by HCV core protein deregulates G2/M phase in HCC cells

A Alisi1, R Mele, A Spaziani

  • 1Dipartimento di Medicina Interna e Sanità Pubblica (M.I.S.P.), University of L'Aquila, L'Aquila, Italy.

Insights

Hepatitis C virus core protein causes cell cycle arrest in liver cancer cells, primarily through PKR pathway inactivation, impacting viral pathogenesis and interferon resistance.

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Hepatitis C virus (HCV) is a primary cause of liver cirrhosis and hepatocellular carcinoma (HCC).
  • HCV core protein influences cellular processes and contributes to HCC development.
  • Understanding HCV core protein's role in cell cycle regulation is crucial for targeting HCC pathogenesis.

Purpose of the Study:

  • To investigate the impact of HCV core protein expression on cell cycle progression in HCC cell lines.
  • To elucidate the specific molecular pathways involved in HCV core protein-induced cell cycle alterations.
  • To explore the implications of these effects on viral pathogenesis and treatment resistance.

Main Methods:

  • Cell cycle analysis using flow cytometry in HepG2 cells expressing HCV core protein.
  • Investigation of the roles of p53 and protein kinase R (PKR) in mediating G2/M phase arrest.
  • Analysis of PKR phosphorylation status and its correlation with eIF-2 phosphorylation.

Main Results:

  • HCV core protein expression led to significant accumulation of HCC cells in the G2/M phase.
  • p53 played a minor role, while PKR inactivation was critical for the observed G2/M arrest.
  • PKR phosphorylation at Thr 446 was elevated in HCC core-positive cells, disrupting mitosis.
  • HCV core protein upregulated PKR activity without increasing eIF-2 phosphorylation, suggesting alternative pathway involvement.

Conclusions:

  • HCV core protein disrupts cell cycle regulation, specifically inducing G2/M arrest via PKR-dependent mechanisms.
  • This disruption may contribute to hepatocellular carcinoma development and resistance to interferon therapy.
  • Alternative PKR-mediated pathways are implicated in HCV pathogenesis and cell cycle deregulation.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.